| __timestamp | Celldex Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 381287000 |
| Thursday, January 1, 2015 | 33837000 | 452612000 |
| Friday, January 1, 2016 | 35979000 | 316800000 |
| Sunday, January 1, 2017 | 25003000 | 330100000 |
| Monday, January 1, 2018 | 19269000 | 265800000 |
| Tuesday, January 1, 2019 | 15426000 | 336200000 |
| Wednesday, January 1, 2020 | 14456000 | 423900000 |
| Friday, January 1, 2021 | 20488000 | 467000000 |
| Saturday, January 1, 2022 | 27195000 | 487000000 |
| Sunday, January 1, 2023 | 30914000 | 477100000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Celldex Therapeutics, Inc. over the past decade.
United Therapeutics has consistently demonstrated robust financial management, with SG&A expenses peaking in 2022 at approximately 487 million USD. This represents a 28% increase from 2014, showcasing their strategic investment in growth and operations.
Conversely, Celldex's SG&A expenses have fluctuated, peaking in 2016 at around 36 million USD before declining to 14 million USD in 2020. This volatility reflects the challenges smaller biotech firms face in scaling operations efficiently.
Understanding these trends provides valuable insights into how these companies allocate resources to drive innovation and maintain competitive advantage.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Novartis AG and United Therapeutics Corporation
Operational Costs Compared: SG&A Analysis of argenx SE and Celldex Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Madrigal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends